South Korea · Biotechnology startup

Genkore

(주)진코어(GenKOre)는 초소형 유전자가위 기술 기반의 독자적 유전자 편집 플랫폼인 ‘TaRGET 시스템’을 개발한 생명과학 연구기업입니다.

Funding reportedLast round: Series A

BiotechnologySouth Korea

About Genkore

(주)진코어(GenKOre)는 초소형 유전자가위 기술 기반의 독자적 유전자 편집 플랫폼인 ‘TaRGET 시스템’을 개발한 생명과학 연구기업입니다.

TaRGET(Tiny nuclease-augment RNA-based Genome Editing Technology)은 단일 AAV 벡터로 전달 가능한 고효율·고안전성 유전자 편집 기술로, 난치성 유전질환 치료에 최적화되어 있습니다.

What company datasets say Genkore raised

Funding, as reported

Reported in all20.7Bin the source's currency
Rounds2
Last roundSeries A
Last round size14.3M
Last round dateOct 2022
Investors listed6

On 3 portfolio pages

Investors who name them

Each firm lists Genkore on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Built with from their website

Google MapsWOWFont AwesomeOpenSSLApacheCloudFlareOWL CarouselMySQLBootstrapOpen Graph

+8 more

jQueryGoogle Maps (Non Paid Users)VimeojQuery MigrateGnuboardcdnjsApache HTTP ServerPHP

Sector
Biotechnology
Region
Daejeon
Full record
Every detail in the company directory

Biotechnology in South Korea

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Genkore in front of investors. Or tell us what we have wrong.